A phase I trial of an anti-pka oligonucleotide (GEM231) administered with weekly CPT-11
A. Craig Lockhart,Charles M. Rudin,Jordan Berlin,Bruce J. Roth,Kenneth R. Hande,R. R. Martin+4 more-2004-07-15-Journal of Clinical Oncology
0
TL;DRAbstract
2074
Chat with Paper
AI Agents for this Paper
2074
Keywords
MedicinePharmacologyInternal medicineOncology
Chat
Click to start Chat